Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Gibson, Roger Carl ^a   Walcott, Geoffery ^b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LORAZEPAM;

CATATONIC SCHIZOPHRENIA; CLINICAL TRIAL; DRUG EFFECT; ELECTROCONVULSIVE THERAPY; HUMAN; MENTAL DISEASE; REVIEW; SYSTEMATIC REVIEW;

EID: 55049120303     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006570.pub2     Document Type: Review

References (49)

1. Arioni 1971 {published data only} Arioni FBM, Gaston A, Pancheri P. Clinical experimentation with the new drug LM-2717 [Sperimentazione clinica di un nuovo farmaco LM 2717]. Rivista di Psichiatria 1971;6(6):409-94. [: PsycINFO 1973-23370-001]
2. Barbee 1992 {published data only} Barbee JG, Mancuso DM, Freed CR, Todorov AA. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia. American Journal of Psychiatry 1992;149:506-10. [MEDLINE: 1348161]
3. Fischer 1974 {published data only} Fischer Cornelssen K, Ferner U, Steiner H. Multifocal psychopharmaceutic testing ("Multihospital trial") [Multifokale Psychopharmakaprufung ("Multihospital Trial")]. Arzneimittel Forschung 1974;24(10):1706-24. [MEDLINE: 75054421]
4. Hekimian 1967 {published data only} Hekimian LJ, Friedhoff AJ. A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients. Diseases of the Nervous System 1967;28(10):675-8. [MEDLINE: 4860896]
5. Holden 1968 {published data only} Holden JM, Itil TM, Keskiner A, Fink M. Thioridazine and chlordiazepoxide, alone and combined, in the treatment of chronic schizophrenia. Comprehensive Psychiatry 1968;9(6):633-43. [MEDLINE: 4883430]
6. Hu 2004 {published data only} Hu W. Investigation of administering BZD medicament in outpatients with psychosis. Heath Psychology Journal 2004;12(1):43, 67. [: 116287]
7. Kunigiri 2002 {published data only} Girish K, Gill NS. Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian Journal of Psychiatry 2003;45:21-5.
8. Kunigiri G, Gill NS, BGN, Naimmagadda J. Electroconvulsive therapy in lorazepam non-responsive catatonia. 12th World Congress of Psychiatry; 2002 Aug 24-29; Yokohama, Japan. 2002. [MEDLINE: 5458933]
9. Kurland 1966 {published data only} Kurland AA, Bethon GD, Michaux MH, Agallianos DD. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment: side effects and clinical laboratory findings. Journal of New Drugs 1966;6:80-95. [MEDLINE: 67014950]
10. Smith 1960 {published data only} Smith ME. A comparative controlled study with chlordiazepoxide. American Journal of Psychiatry 1960;117:362-3. [MEDLINE: 4556217]
11. Smith 1961 {published data only} Smith ME. A clinical study of chlorpromazine and chlordiazepoxide. Connecticut State Medical Journal 1961;25:153-7.
12. Ungvari 1997 {published data only} Ungvari GS, Chow LY, Chiu HFK, Lau B. Diiferent treatment response of distinct schizophrenia subtypes: the group of systematic catatonias. 6th world Congress of Biological Psychiatry; 1997 Jun 22-27; Nice, France. 1997.
13. Vasquez-Gomez 2001 {published data only} Vasquez-Gomez F. The use of midazolam for control of acutely agitated outpatients in psychiatry emergency. 7th World Congress of Biological Psychiatry; 2001 Jul 1-6; Berlin, Germany. 2001; Vol. 2, issue Suppl 1. [: 7th World Congress of Biological Psychiatry [CD-ROM]: Conifer, Excerpta Medica Medical Communications BV, 2001 P034-02]
14. Weckowicz 1960 {published data only} Weckowicz TE, Ward T. Clinical trial of RO 5-0690 and chlorpromazine on disturbed chronic schizophrenic patients. Diseases of the Nervous System 1960;21:527-8. [MEDLINE: 13783681]
15. Wolkowitz 1988 {published data only} Wolkowitz OM, Breier A, Doran A, Kelsoe J, Lucas P, Paul SM, Pickar D. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients - preliminary results. Archives of General Psychiatry 1988;45(7):664-71. [MEDLINE: 88251245; : PsycINFO 76-02568]
16. WolkowitzOM, Pickar D, Doran AR, Breier A, Tarell J, Paul SM. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia. American Journal of Psychiatry 1986;143(1):85-7.
17. Wolkowitz 1992 {published data only} Wolkowitz OM, Turetsky N, Reus VI, Hargreaves WA. Benzodiazepine augmentation of neuroleptics in treatment resistant schizophrenia. Psychopharmacology Bulletin 1992;28(3):291-5. [MEDLINE: 1362277; : PsycINFO 80-18793]
18. Wolkowitz 1993 {published data only} Wolkowitz OM, Harris D, Turetsky NG, Reus VI, Johnson R, Gustafson M, Espinoza S, Petty F, Cooper TB, Sheline Y, Hargreaves WA. Alprazolam-neuroleptic treatment of schizophrenia. 146th Annual Meeting of the American Psychiatric Association; 1993 May 22-27; San Francisco, California, USA. 1993:119.
19. Wyant 1990 {published data only} Wyant M, Diamond BI, O'Neal E, Sloan A, Borison RL. The use of midazolam in acutely agitated psychiatric patients. Psychopharmacology Bulletin 1990;26(1):126- 9. [MEDLINE: 2371367; : PsycINFO 79-28483]
20. Merlis 1962 {published data only} Merlis S, Turner WJ, Krumholz W. A double-blind comparison of diazepam, chlordiazepoxide and chlorpromazine in psychotic patients. Journal of Neuropsychiatry 1962;3(Suppl 1):S133-8. [: PsycINFO 1977-03995-001]
21. Patra 1998 {published data only} Patra A, Sarkar A, Kumar R. Outcome of lorazepam in catatonia oral vs parenteral administration. Indian Journal of Psychiatry 1998:91. [MEDLINE: 8442962]
22. Schmider 1999 {published data only} Schmider J, Standhart H, Deuschle M, Drancoli J, Heuser I. A double blind comparison of lorazepam and oxazepamin psychogenic catatonia. 10th European College of Neuropsychopharmacology Congress; 1997 Sep 13-17; Vienna, Austria. 1997.
23. Schmider J, Standhart H, Deuschle M, Drancoli J, Heuser I. A double blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. Biological Psychiatry 1999;46(3):437-41. [MEDLINE: 99364070; : EMBASE 1999252184]
24. Ungvari 1999 {published data only} Pang AHT, Ungvari G, Ng FS, Chiu H. Treatment response of systematic catatonia (leonhard) to lorazepam. 21st Collegium Internationale neuro-Psychopharmacologicum Congress; 1998 Jul 12-16; Glasgow, UK. 1998.
25. Ungvari G, Pang A, Ng F, Chiu H, Wong C. Treatment response studies in systematic catatonia (leonhard). i. lorazepamchallenge. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7-12; London, UK. 1996.
26. Ungvari GS, Chiu HF, Chow LY, Lau BS, Tang WK. Lorazepam for chronic catatonia: a randomized, double blind, placebo controlled cross over study. Psychopharmacology Berlin 1999;142(4):393-8. [MEDLINE: 10229064]
27. Wetzel 1997 {published data only} Wetzel H, Klawe CJ, Muller MJ, Wiesner J, Benkert O. Lorazepam for stupor and mutism: a double-blind placebo-controlled cross-over study. 10th European College of Neuropsychopharmacology Congress; 1997 Sep 13-17; Vienna, Austria. 1997. [MEDLINE: 79123210]
28. Altman 1996 Altman DG, Bland JM. Detecing skewness from summary information. BMJ 1996;313:1200. [: OLZ020600]
29. APA 2000 American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV TR). 4th Edition. Washington: American Psychiatric Association, 2000.
30. Bland 1997 Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
31. Boissel 1999 Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, Boutitie F, Nony P, Haugh M, Mignot G. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use. Therapie 1999;54(4):405-11.
32. Deeks 2000 Deeks J. Issues in the selection for meta-analyses of binary data. Abstracts of 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa. 2000.
33. Divine 1992 Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-9.
34. Donner 2002 Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-80.
35. Elbourne 2002 Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues.. Int J Epidemiol 2002;31(1):140-9.
36. Gulliford 1999 Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83.
37. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-60.
38. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. www.cochrane.org/resources/handbook/hbook.htm (accessed 04 February 2006).
39. Kahlbaum 1973 Kahlbaum KL. Catatonia [Die Katatonie oder das spannungirresein]. Catatonia. Baltimore: Johns Hopkins University Press, 1973.
40. Kay 1986 Kay SR, Opler LA, Fiszbein A. Positive and negative syndrome scale (PANSS) manual. North Tonawanda (NY): Multi-Health Systems, 1986.
41. Leucht 2005a Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale Scores. British Journal of Psychiatry 2005;187:366-71.
42. Leucht 2005b Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. What does the PANSS mean?. Schizophrenia Research 2005;79:231-8.
43. Marshall 2000 Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
44. Overall 1962 Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10:799-812.
45. Penland 2006 Penland HR, Weder N, Tampi RR. The catatonic dilemma expanded. Annals of General Psychiatry 2006;5:14.
46. Regestein 1977 Regestein QR, Alpert JS, Reich P. Sudden catatonic stupor with disastrous outcome. Journal of the American Medical Association 1977;238:618-20.
47. Rosebush 1990 Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. Journal of Clinical Psychiatry 1990;51:357-62.
48. Ukoumunne 1999 Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-75.
49. WHO 1992 World Health Organization. ICD-10: international statistical classification of diseases and related health problems. Geneva: World Health Association, 1992.